HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells.

Abstract
The present studies reveal the antiproliferative property of diallyl disulfide (DADS) in cultured human colon tumor cells (HCT-15) relative to its ability to decrease the proportion of cells in the G1 phase and increase the proportion of cells in the G2/M phase. The shift in the proportion of cells blocked in the G2/M phase increased as the concentration and duration of DADS exposure increased. Refeeding DADS-treated cells (50 microM) with complete medium without DADS resulted in a return to normal proliferation rates. Consistent with the G2/M phase arrest, DADS exposure inhibited p34cdc2 kinase activity within four hours of treatment. The maximum depression in p34cdc2 kinase activity (53%) occurred when 25 microM DADS was added to the medium. The present studies suggest that depressed p34cdc2 kinase activity is likely one of the early cellular events that may account for the antiproliferative property of DADS.
AuthorsL M Knowles, J A Milner
JournalNutrition and cancer (Nutr Cancer) Vol. 30 Issue 3 Pg. 169-74 ( 1998) ISSN: 0163-5581 [Print] United States
PMID9631486 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Allyl Compounds
  • Antineoplastic Agents
  • Disulfides
  • diallyl disulfide
  • CDC2 Protein Kinase
Topics
  • Allyl Compounds (pharmacology)
  • Antineoplastic Agents (pharmacology)
  • CDC2 Protein Kinase (metabolism)
  • Cell Cycle
  • Colonic Neoplasms (enzymology, prevention & control)
  • Disulfides (pharmacology)
  • Humans
  • Tumor Cells, Cultured (cytology, enzymology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: